HLA-B and aneurysmal bone cyst: Importantly, the study also identified cases where patients developed ABC HSRs despite testing negative for HLA-B*5701, emphasizing the necessity for continued monitoring and exploring additional genetic markers or risk factors associated with ABC adverse reactions.